X0303 4 2011-07-01 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001325713 Kovner Bruce C/O CAXTON ASSOCIATES LP 500 PARK AVENUE NEW YORK NY 10022 1 0 1 0 Common Stock 2011-07-01 4 A 0 7858 0 A 4765124 D Common Stock 7761716 I By CxSynta LLC Director Stock Option (Right to Buy) 5.09 2011-07-01 4 A 0 5500 0 A 2021-07-01 Common Stock 5500 5500 D Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2011, December 31, 2011, March 31, 2012 and June 30, 2012, provided the Reporting Person continues to serve as a director of the Issuer on such date. These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as Chairman of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The option vests as to 25% of the shares on each of September 30, 2011, December 31, 2011, March 31, 2012 and June 30, 2012, provided the Reporting Person continues to serve as a director of the Issuer on such date. /s/ Scott B. Bernstein, Attorney-in-Fact 2011-07-06